- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03939221
Measure the Meridian Energy Change of Terminal Hospice Patient Via Meridian Energy Analysis Device
Measure the Meridian Energy Change of Terminal Hospice Patient Via Meridian Energy Analysis Device to Evaluated the Relationship of Clinical Symptoms and Alternative Medicine Effect.
Study Overview
Status
Intervention / Treatment
Detailed Description
In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. It may be caused by cancer or multiple kinds of organ failure. The terminal hospital patients have symptoms such as pain, dyspnea, fatigue, nausea, vomiting, poor appetite, constipation, ileus or edema…, etc. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine.
First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients (divided to cancer, multiple kinds of organ failure). It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, investigators use the intervention of complementary and alternative medicine (like infrared lamp and acupressure…, etc.) to improve the quality of life in the terminal hospice patients. Also, investigators will use the Meridian Energy Analysis Device, pain scale, vital signs and quality of life scale (SF-36) to evaluate the effects of complementary and alternative medicine.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Changhua, Taiwan, 500
- Changhua Christian Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients lived at our Changhua Christian Hospital hospice ward
- From 2019-02~2020-12, age 20 to 99 years old, volunteer patient
Exclusion Criteria:
- Unwillingness
- Wound or amputation near wrist or ankle
- Severe agitation or seizure patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention of infrared lamp and acupressure
Measure the ankle and wrist acupoints skin conductance to evaluate the basic condition of terminal hospice patients.
Then investigators use the infrared lamp and acupressure(tender points, PC6(neiguan) and ST36(zusanli) for one minutes) for our patient for the cold limbs, pain control and constipation problems.
|
Measure the ankle and wrist acupoints skin conductance to evaluate the basic condition of terminal hospice patients.
Then investigators use the infrared lamp and acupressure(tender points, PC6 and ST36 for one minutes) for our patient for the cold limbs, pain control and constipation problems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of 24 points skin electric conductance over bilateral wrist and foot in terminal patients
Time Frame: through hospitalization period, an average of 1 month (after admission baseline evaluation and till discharge)
|
Investigators use the meridian energy analysis device to measure the 24 points skin conductance over bilateral wrist and foot.
The meridian energy analysis device is an electrophysiology tool to measure the skin micro-electrical currents(range from 0uA to 200uA).
The higher skin conductance stands for better condition of patient.
Investigators will evaluate the relationship between the skin conductances and clinical symptoms.
Then investigators will check the effect via the skin electric conductance before and after the infrared lamp and acupressure intervention.
|
through hospitalization period, an average of 1 month (after admission baseline evaluation and till discharge)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ming-Cheng Chung, Bachelor, Changhua Christian Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CCH-181018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Survival
-
Peking University First HospitalCompletedOverall SurvivalChina
-
Columbia UniversityBill and Melinda Gates Foundation; United NationsCompletedChild SurvivalEthiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Rwanda, Senegal, Tanzania, Uganda
-
University of SienaCompletedRestoration Survival
-
Metabolic Technologies Inc.Koach Sport and NutritionCompletedSurvival TrainingIsrael
-
ChimerixTerminated
-
Universitair Ziekenhuis BrusselCompletedSurvival | Embryo QualityBelgium
-
Technical University of MunichUnknown
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
University Medical Center GroningenCompletedSurvival | Immediate Dentin Sealing
-
Peking Union Medical College HospitalOrigiMedRecruitingQuality of Life | Objective Response Rate | Overall Survival | Progression-free Survival | Disease Control Rate | Duration of Response | Five-year Survival RateChina
Clinical Trials on Infrared Lamp and Acupressure
-
Avita MedicalTerminated
-
Cairo UniversityCompletedPrimary Antiphospholipid SyndromeEgypt
-
Taichung Veterans General HospitalCompleted
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Heilongjiang University of Chinese MedicineUnknownPolycystic Ovary SyndromeChina
-
Akdeniz UniversityCompletedPediatric Cancer | Nausea With Vomiting Chemotherapy-InducedTurkey
-
Stanford UniversityCenters for Disease Control and Prevention; International Centre for Diarrhoeal...Not yet recruitingSARS-CoV2 Infection | Influenza Viral Infections | Respiratory Viral Infection
-
Inha University HospitalNational Research Foundation of KoreaTerminatedSmokingKorea, Republic of
-
Heilongjiang University of Chinese MedicineUnknownPolycystic Ovary Syndrome | Insulin ResistanceChina